Understanding Congestive Heart Failure with Preserved Ejection Fraction (CHFpEF), also known as Heart Failure with Preserved Ejection Fraction or Diastolic Heart Failure, is crucial for accurate clinical documentation and medical coding. This resource provides information on CHFpEF diagnosis, treatment, and management, including relevant ICD-10 codes and clinical terminology for healthcare professionals. Learn about the symptoms, causes, and prognosis of Diastolic Heart Failure and improve your understanding of this complex cardiac condition.
Also known as
Heart failure with preserved ejection fraction
Heart failure where the ejection fraction is normal or above normal.
Other heart failure
Unspecified heart failure and heart failure with other specified abnormalities.
Heart failure
Encompasses various types of heart failure, including specified and unspecified.
Hypertensive heart disease with heart failure
Heart failure caused by high blood pressure.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the EF documented as preserved (>=50%)?
When to use each related code
| Description |
|---|
| Heart failure with normal ejection fraction. |
| Heart failure with reduced ejection fraction. |
| General term for heart's inability to pump efficiently. |
Coding CHFpEF as unspecified HF if EF details are missing from documentation leads to lower reimbursement and data inaccuracy.
Incorrectly coding related conditions like hypertension or atrial fibrillation as separate from CHFpEF can impact severity scores.
Lack of clear EF value and measurement method in documentation to support CHFpEF diagnosis creates audit risk and coding errors.
Q: What are the most effective diagnostic strategies for differentiating Heart Failure with Preserved Ejection Fraction (HFpEF) from other causes of dyspnea in older adults?
A: Differentiating HFpEF from other causes of dyspnea in older adults can be challenging due to overlapping symptoms. A comprehensive approach is crucial, beginning with a thorough clinical history and physical exam, paying close attention to signs like exertional dyspnea, orthopnea, and peripheral edema. Echocardiography plays a vital role, assessing left ventricular ejection fraction (LFEF), diastolic function parameters (e.g., E/e' ratio, left atrial volume), and valvular abnormalities. However, a normal LFEF does not exclude HFpEF. Natriuretic peptide levels (BNP/NT-proBNP) can be helpful, particularly when elevated. Exercise stress testing, with or without imaging, can unmask exercise-induced pulmonary hypertension and assess functional capacity. Cardiac MRI can provide further insights into myocardial structure and function. In complex cases, invasive hemodynamic assessment may be necessary. Consider implementing a multi-modal diagnostic pathway that incorporates these strategies to improve diagnostic accuracy in older adults. Explore how S10.AI can assist in streamlining the diagnostic process for HFpEF.
Q: How does the management of Congestive Heart Failure with Preserved Ejection Fraction (CHFpEF) differ from that of Heart Failure with Reduced Ejection Fraction (HFrEF) in terms of pharmacotherapy and lifestyle interventions?
A: While both CHFpEF and HFrEF share the overarching goal of symptom control and improving quality of life, their management differs significantly, especially regarding pharmacotherapy. Unlike HFrEF, no medications have consistently demonstrated a mortality benefit in CHFpEF. Current guidelines recommend managing comorbidities aggressively, including hypertension, diabetes, and atrial fibrillation. Diuretics are essential for managing fluid overload and relieving congestion. Control of hypertension with agents like ACE inhibitors, ARBs, or beta-blockers is crucial. Mineralocorticoid receptor antagonists (MRAs) may be considered in select patients. Lifestyle interventions are paramount for both HFpEF and HFrEF, emphasizing sodium restriction, regular exercise, and weight management. However, the specific exercise recommendations might differ based on individual patient characteristics and functional capacity. Learn more about the nuances of CHFpEF management and explore how S10.AI can support personalized treatment strategies.
Patient presents with complaints consistent with congestive heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure. Symptoms include dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea, and fatigue. Physical exam reveals bibasilar rales, elevated jugular venous pressure, and peripheral edema. Left ventricular ejection fraction (LVEF) is greater than or equal to 50% based on recent echocardiogram, confirming preserved systolic function. The patient's medical history includes hypertension, diabetes mellitus, and obesity, all significant risk factors for HFpEF. Diagnosis of HFpEF is based on the presence of typical symptoms and signs of heart failure, normal or mildly reduced LVEF, and evidence of diastolic dysfunction, such as impaired left ventricular relaxation or elevated filling pressures. Differential diagnoses considered include chronic obstructive pulmonary disease (COPD) and other causes of pulmonary edema. Treatment plan includes optimization of medical therapy for hypertension and diabetes, diuretics for fluid management, and patient education on lifestyle modifications, including sodium restriction and regular exercise. Follow-up echocardiography and BNP levels will be monitored to assess treatment response. Patient advised to report any worsening of symptoms or new onset of chest pain. ICD-10 code I50.31, diastolic heart failure, is recorded for this encounter.